APAZA Trademark

Trademark Overview

On Tuesday, August 22, 2017, a trademark application was filed for APAZA with the United States Patent and Trademark Office. The USPTO has given the APAZA trademark a serial number of 87578365. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 19, 2020. This trademark is owned by Innovate Biopharmaceuticals Inc.. The APAZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, aminosalicylic acid and an immunomodulator coupled by an azo bond, in orally administrable form for the treatment of inflammatory bowel disease
apaza

General Information

Serial Number87578365
Word MarkAPAZA
Filing DateTuesday, August 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 19, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, aminosalicylic acid and an immunomodulator coupled by an azo bond, in orally administrable form for the treatment of inflammatory bowel disease
Translation of Words in MarkThe wording "APAZA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 26, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInnovate Biopharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27615
Party NameInnovate Biopharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27615

Trademark Events

Event DateEvent Description
Monday, October 19, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 19, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, March 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 4, 2020EXTENSION 3 GRANTED
Wednesday, March 4, 2020EXTENSION 3 FILED
Wednesday, March 4, 2020TEAS EXTENSION RECEIVED
Friday, September 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 18, 2019EXTENSION 2 GRANTED
Wednesday, September 18, 2019EXTENSION 2 FILED
Wednesday, September 18, 2019TEAS EXTENSION RECEIVED
Wednesday, March 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 18, 2019EXTENSION 1 GRANTED
Monday, March 18, 2019EXTENSION 1 FILED
Monday, March 18, 2019TEAS EXTENSION RECEIVED
Tuesday, September 18, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 11, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 5, 2018ASSIGNED TO LIE
Tuesday, May 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2017NON-FINAL ACTION E-MAILED
Wednesday, November 29, 2017NON-FINAL ACTION WRITTEN
Tuesday, November 28, 2017ASSIGNED TO EXAMINER
Saturday, August 26, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 25, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

apaza form administrable treatment inflammatory disease bowel orally bond namely preparations